Skip to main content
Erschienen in: Quality of Life Research 10/2015

01.10.2015

How to interpret multidimensional quality of life questionnaires for patients with schizophrenia?

verfasst von: Pierre Michel, Pascal Auquier, Karine Baumstarck, Anderson Loundou, Badih Ghattas, Christophe Lançon, Laurent Boyer

Erschienen in: Quality of Life Research | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The classification of patients into distinct categories of quality of life (QoL) levels may be useful for clinicians to interpret QoL scores from multidimensional questionnaires. The aim of this study had been to define clusters of QoL levels from a specific multidimensional questionnaire (SQoL18) for patients with schizophrenia by using a new method of interpretable clustering and to test its validity regarding socio-demographic, clinical, and QoL information.

Methods

In this multicentre cross-sectional study, patients with schizophrenia have been classified using a hierarchical top-down method called clustering using unsupervised binary trees (CUBT). A three-group structure has been employed to define QoL levels as “high”, “moderate”, or “low”. Socio-demographic, clinical, and QoL data have been compared between the three clusters to ensure their clinical relevance.

Results

A total of 514 patients have been analysed: 78 are classified as “low”, 265 as “moderate”, and 171 as “high”. The clustering shows satisfactory statistical properties, including reproducibility (using bootstrap analysis) and discriminancy (using factor analysis). The three clusters consistently differentiate patients. As expected, individuals in the “high” QoL level cluster report the lowest scores on the Positive and Negative Syndrome Scale (p = 0.01) and the Calgary Depression Scale (p < 0.01), and the highest scores on the Global Assessment of Functioning (p < 0.03), the SF36 (p < 0.01), the EuroQol (p < 0.01), and the Quality of Life Inventory (p < 0.01).

Conclusion

Given the ease with which this method can be applied, classification using CUBT may be useful for facilitating the interpretation of QoL scores in clinical practice.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Awad, A. G., & Voruganti, L. N. (2012). Measuring quality of life in patients with schizophrenia: An update. Pharmacoeconomics, 30(3), 183–195.CrossRefPubMed Awad, A. G., & Voruganti, L. N. (2012). Measuring quality of life in patients with schizophrenia: An update. Pharmacoeconomics, 30(3), 183–195.CrossRefPubMed
2.
Zurück zum Zitat Bobes, J., Garcia-Portilla, P., Saiz, P. A., Bascaran, T., & Bousono, M. (2005). Quality of life measures in schizophrenia. European Psychiatry, 20(Suppl 3), S313–S317.CrossRefPubMed Bobes, J., Garcia-Portilla, P., Saiz, P. A., Bascaran, T., & Bousono, M. (2005). Quality of life measures in schizophrenia. European Psychiatry, 20(Suppl 3), S313–S317.CrossRefPubMed
3.
Zurück zum Zitat Cramer, J. A., Rosenheck, R., Xu, W., Thomas, J., Henderson, W., & Charney, D. S. (2000). Quality of life in schizophrenia: A comparison of instruments. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Schizophrenia Bulletin, 26(3), 659–666.CrossRefPubMed Cramer, J. A., Rosenheck, R., Xu, W., Thomas, J., Henderson, W., & Charney, D. S. (2000). Quality of life in schizophrenia: A comparison of instruments. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Schizophrenia Bulletin, 26(3), 659–666.CrossRefPubMed
4.
Zurück zum Zitat Hayhurst, K. P., Drake, R. J., Massie, J. A., Dunn, G., Barnes, T. R., Jones, P. B., & Lewis, S. W. (2013). Improved quality of life over one year is associated with improved adherence in patients with schizophrenia. European Psychiatry, 29(3), 191–196.CrossRefPubMed Hayhurst, K. P., Drake, R. J., Massie, J. A., Dunn, G., Barnes, T. R., Jones, P. B., & Lewis, S. W. (2013). Improved quality of life over one year is associated with improved adherence in patients with schizophrenia. European Psychiatry, 29(3), 191–196.CrossRefPubMed
5.
Zurück zum Zitat Boyer, L., Lancon, C., Baumstarck, K., Parola, N., Berbis, J., & Auquier, P. (2013). Evaluating the impact of a quality of life assessment with feedback to clinicians in patients with schizophrenia: Randomised controlled trial. British Journal of Psychiatry, 202, 447–453.CrossRefPubMed Boyer, L., Lancon, C., Baumstarck, K., Parola, N., Berbis, J., & Auquier, P. (2013). Evaluating the impact of a quality of life assessment with feedback to clinicians in patients with schizophrenia: Randomised controlled trial. British Journal of Psychiatry, 202, 447–453.CrossRefPubMed
6.
Zurück zum Zitat Boyer, L., Millier, A., Perthame, E., Aballea, S., Auquier, P., & Toumi, M. (2013). Quality of life is predictive of relapse in schizophrenia. BMC Psychiatry, 13, 15.PubMedCentralCrossRefPubMed Boyer, L., Millier, A., Perthame, E., Aballea, S., Auquier, P., & Toumi, M. (2013). Quality of life is predictive of relapse in schizophrenia. BMC Psychiatry, 13, 15.PubMedCentralCrossRefPubMed
7.
Zurück zum Zitat Caqueo-Urizar, A., Gutierrez-Maldonado, J., & Miranda-Castillo, C. (2009). Quality of life in caregivers of patients with schizophrenia: A literature review. Health and Quality of Life Outcomes, 7, 84.PubMedCentralCrossRefPubMed Caqueo-Urizar, A., Gutierrez-Maldonado, J., & Miranda-Castillo, C. (2009). Quality of life in caregivers of patients with schizophrenia: A literature review. Health and Quality of Life Outcomes, 7, 84.PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Testart, J., Richieri, R., Caqueo-Urizar, A., Lancon, C., Auquier, P., & Boyer, L. (2013). Quality of life and other outcome measures in caregivers of patients with schizophrenia. Expert Review of Pharmacoeconomics & Outcomes Research, 13(5), 641–649.CrossRef Testart, J., Richieri, R., Caqueo-Urizar, A., Lancon, C., Auquier, P., & Boyer, L. (2013). Quality of life and other outcome measures in caregivers of patients with schizophrenia. Expert Review of Pharmacoeconomics & Outcomes Research, 13(5), 641–649.CrossRef
9.
Zurück zum Zitat Halyard, M. Y., Frost, M. H., & Dueck, A. (2006). Integrating QOL assessments for clinical and research purposes. Current Problems in Cancer, 30(6), 319–330.CrossRefPubMed Halyard, M. Y., Frost, M. H., & Dueck, A. (2006). Integrating QOL assessments for clinical and research purposes. Current Problems in Cancer, 30(6), 319–330.CrossRefPubMed
10.
Zurück zum Zitat Halyard, M. Y., Frost, M. H., Dueck, A., & Sloan, J. A. (2006). Is the use of QOL data really any different than other medical testing? Current Problems in Cancer, 30(6), 261–271.CrossRefPubMed Halyard, M. Y., Frost, M. H., Dueck, A., & Sloan, J. A. (2006). Is the use of QOL data really any different than other medical testing? Current Problems in Cancer, 30(6), 261–271.CrossRefPubMed
11.
Zurück zum Zitat Awad, A. G. (2012). Quality-of-life assessment in schizophrenia: The unfulfilled promise. Expert Review of Pharmacoeconomics & Outcomes Research, 11(5), 491–493.CrossRef Awad, A. G. (2012). Quality-of-life assessment in schizophrenia: The unfulfilled promise. Expert Review of Pharmacoeconomics & Outcomes Research, 11(5), 491–493.CrossRef
12.
Zurück zum Zitat Greenhalgh, J., Long, A. F., & Flynn, R. (2005). The use of patient reported outcome measures in routine clinical practice: Lack of impact or lack of theory? Social Science and Medicine, 60(4), 833–843.CrossRefPubMed Greenhalgh, J., Long, A. F., & Flynn, R. (2005). The use of patient reported outcome measures in routine clinical practice: Lack of impact or lack of theory? Social Science and Medicine, 60(4), 833–843.CrossRefPubMed
13.
Zurück zum Zitat Boyer, L., Baumstarck, K., Boucekine, M., Blanc, J., Lancon, C., & Auquier, P. (2013). Measuring quality of life in patients with schizophrenia:an overview. Expert Review of Pharmacoeconomics & Outcomes Research, 13(3), 343–349.CrossRef Boyer, L., Baumstarck, K., Boucekine, M., Blanc, J., Lancon, C., & Auquier, P. (2013). Measuring quality of life in patients with schizophrenia:an overview. Expert Review of Pharmacoeconomics & Outcomes Research, 13(3), 343–349.CrossRef
14.
Zurück zum Zitat McGorry, P. D., Nelson, B., Goldstone, S., & Yung, A. R. (2010). Clinical staging: A heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. Canadian Journal of Psychiatry, 55(8), 486–497. McGorry, P. D., Nelson, B., Goldstone, S., & Yung, A. R. (2010). Clinical staging: A heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. Canadian Journal of Psychiatry, 55(8), 486–497.
15.
Zurück zum Zitat Lin, A., Reniers, R. L., & Wood, S. J. (2013). Clinical staging in severe mental disorder: Evidence from neurocognition and neuroimaging. British Journal of Psychiatry, Suppl. 54, s11–s17.CrossRef Lin, A., Reniers, R. L., & Wood, S. J. (2013). Clinical staging in severe mental disorder: Evidence from neurocognition and neuroimaging. British Journal of Psychiatry, Suppl. 54, s11–s17.CrossRef
16.
Zurück zum Zitat Fraiman, F., Ghattas, G., & Svarc, M. (2013). Interpretable clustering using unsupervised binary trees. R package experimental version: CUBT for windows. CUBT for Linux. Fraiman, F., Ghattas, G., & Svarc, M. (2013). Interpretable clustering using unsupervised binary trees. R package experimental version: CUBT for windows. CUBT for Linux.
17.
Zurück zum Zitat Michel, P., Baumstarck, K., Boyer, L., Fernandez, O., Flachenecker, P., Pelletier, J., Loundou, A., Ghattas, B., & Auquier, P. (2014). Defining quality of life levels to enhance clinical interpretation in multiple sclerosis: Application of a novel clustering method. Medical Care. Michel, P., Baumstarck, K., Boyer, L., Fernandez, O., Flachenecker, P., Pelletier, J., Loundou, A., Ghattas, B., & Auquier, P. (2014). Defining quality of life levels to enhance clinical interpretation in multiple sclerosis: Application of a novel clustering method. Medical Care.
18.
Zurück zum Zitat Boyer, L., Simeoni, M. C., Loundou, A., D’Amato, T., Reine, G., Lancon, C., & Auquier, P. (2010). The development of the S-QoL 18: A shortened quality of life questionnaire for patients with schizophrenia. Schizophrenia Research, 121(1–3), 241–250.CrossRefPubMed Boyer, L., Simeoni, M. C., Loundou, A., D’Amato, T., Reine, G., Lancon, C., & Auquier, P. (2010). The development of the S-QoL 18: A shortened quality of life questionnaire for patients with schizophrenia. Schizophrenia Research, 121(1–3), 241–250.CrossRefPubMed
19.
Zurück zum Zitat APA. (1994). DSM-IV. Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association. APA. (1994). DSM-IV. Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.
20.
Zurück zum Zitat CNIL. (2004). Act n°78-17 of 6 January 1978 on Data Processing, Data Files and Individual Liberties (amended by the Act of 6 August 2004 relating to the protection of individuals with regard to the processing of personal data). Journal officiel de la République Française. Assemblée Nationale et Sénat. France. CNIL. (2004). Act n°78-17 of 6 January 1978 on Data Processing, Data Files and Individual Liberties (amended by the Act of 6 August 2004 relating to the protection of individuals with regard to the processing of personal data). Journal officiel de la République Française. Assemblée Nationale et Sénat. France.
21.
Zurück zum Zitat WMA. (2008). Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects. Seoul: World Medical Association, General Assembly. WMA. (2008). Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects. Seoul: World Medical Association, General Assembly.
22.
Zurück zum Zitat Kay, S. R., Opler, L. A., & Fiszbein, A. (1986). Significance of positive and negative syndromes in chronic schizophrenia. British Journal of Psychiatry, 149, 439–448.CrossRefPubMed Kay, S. R., Opler, L. A., & Fiszbein, A. (1986). Significance of positive and negative syndromes in chronic schizophrenia. British Journal of Psychiatry, 149, 439–448.CrossRefPubMed
23.
Zurück zum Zitat Addington, D., Addington, J., & Maticka-Tyndale, E. (1993). Assessing depression in schizophrenia: The Calgary Depression Scale. British Journal of Psychiatry. Supplement, 22, 39–44. Addington, D., Addington, J., & Maticka-Tyndale, E. (1993). Assessing depression in schizophrenia: The Calgary Depression Scale. British Journal of Psychiatry. Supplement, 22, 39–44.
24.
Zurück zum Zitat Endicott, R. L., Spitzer, J. L., & Fleiss, J. C. (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33, 766–771.CrossRefPubMed Endicott, R. L., Spitzer, J. L., & Fleiss, J. C. (1976). The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry, 33, 766–771.CrossRefPubMed
25.
Zurück zum Zitat Ware, J. E. J., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473–483.CrossRefPubMed Ware, J. E. J., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473–483.CrossRefPubMed
26.
Zurück zum Zitat EuroQoL. (1990). EuroQol—a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy, 16(3), 199–208.CrossRef EuroQoL. (1990). EuroQol—a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy, 16(3), 199–208.CrossRef
27.
Zurück zum Zitat Lehman, A. F. (1983). The well-being of chronic mental patients. Archives of General Psychiatry, 40(4), 369–373.CrossRefPubMed Lehman, A. F. (1983). The well-being of chronic mental patients. Archives of General Psychiatry, 40(4), 369–373.CrossRefPubMed
28.
Zurück zum Zitat Lehman, A. F. (1988). A quality of life interview for the chronically mentally ill. Evaluation and program planning, 11, 51–62.CrossRef Lehman, A. F. (1988). A quality of life interview for the chronically mentally ill. Evaluation and program planning, 11, 51–62.CrossRef
29.
Zurück zum Zitat Auquier, P., Simeoni, M. C., Sapin, C., Reine, G., Aghababian, V., Cramer, J., & Lancon, C. (2003). Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: The S-QoL. Schizophrenia Research, 63(1–2), 137–149.CrossRefPubMed Auquier, P., Simeoni, M. C., Sapin, C., Reine, G., Aghababian, V., Cramer, J., & Lancon, C. (2003). Development and validation of a patient-based health-related quality of life questionnaire in schizophrenia: The S-QoL. Schizophrenia Research, 63(1–2), 137–149.CrossRefPubMed
30.
Zurück zum Zitat Baumstarck, K., Boyer, L., Boucekine, M., Aghababian, V., Parola, N., Lancon, C., & Auquier, P. (2013). Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment. Schizophrenia Research, 147(1), 58–67.CrossRefPubMed Baumstarck, K., Boyer, L., Boucekine, M., Aghababian, V., Parola, N., Lancon, C., & Auquier, P. (2013). Self-reported quality of life measure is reliable and valid in adult patients suffering from schizophrenia with executive impairment. Schizophrenia Research, 147(1), 58–67.CrossRefPubMed
31.
Zurück zum Zitat Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984). Classification and regression trees. Monterey: Wadsworth Inc. Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984). Classification and regression trees. Monterey: Wadsworth Inc.
32.
Zurück zum Zitat Luckett, T., Butow, P. N., & King, M. T. (2009). Improving patient outcomes through the routine use of patient-reported data in cancer clinics: Future directions. Psychooncology, 18(11), 1129–1138.CrossRefPubMed Luckett, T., Butow, P. N., & King, M. T. (2009). Improving patient outcomes through the routine use of patient-reported data in cancer clinics: Future directions. Psychooncology, 18(11), 1129–1138.CrossRefPubMed
33.
Zurück zum Zitat Boyer, L., Richieri, R., Faget, C., Padovani, R., Vaillant, F., Mundler, O., et al. (2012). Functional involvement of superior temporal sulcus in quality of life of patients with schizophrenia. Psychiatry Research, 202(2), 155–160.CrossRefPubMed Boyer, L., Richieri, R., Faget, C., Padovani, R., Vaillant, F., Mundler, O., et al. (2012). Functional involvement of superior temporal sulcus in quality of life of patients with schizophrenia. Psychiatry Research, 202(2), 155–160.CrossRefPubMed
34.
Zurück zum Zitat Cosci, F., & Fava, G. A. (2013). Staging of mental disorders: Systematic review. Psychotherapy and Psychosomatics, 82(1), 20–34.CrossRefPubMed Cosci, F., & Fava, G. A. (2013). Staging of mental disorders: Systematic review. Psychotherapy and Psychosomatics, 82(1), 20–34.CrossRefPubMed
35.
Zurück zum Zitat McKenna, S. P. (1997). Measuring quality of life in schizophrenia. European Psychiatry, 12, 267–274.CrossRef McKenna, S. P. (1997). Measuring quality of life in schizophrenia. European Psychiatry, 12, 267–274.CrossRef
36.
Zurück zum Zitat Ascher-Svanum, H., Novick, D., Haro, J. M., Aguado, J., & Cui, Z. (2012). Empirically driven definitions of “good,” “moderate,” and “poor” levels of functioning in the treatment of schizophrenia. Quality of Life Research, 22(8), 2085–2094.PubMedCentralCrossRefPubMed Ascher-Svanum, H., Novick, D., Haro, J. M., Aguado, J., & Cui, Z. (2012). Empirically driven definitions of “good,” “moderate,” and “poor” levels of functioning in the treatment of schizophrenia. Quality of Life Research, 22(8), 2085–2094.PubMedCentralCrossRefPubMed
37.
Zurück zum Zitat Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T, Jr. (1984). The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 10(3), 388–398.CrossRefPubMed Heinrichs, D. W., Hanlon, T. E., & Carpenter, W. T, Jr. (1984). The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophrenia Bulletin, 10(3), 388–398.CrossRefPubMed
38.
Zurück zum Zitat Baraldi, A. N., & Enders, C. K. (2010). An introduction to modern missing data analyses. Journal of School Psychology, 48(1), 5–37.CrossRefPubMed Baraldi, A. N., & Enders, C. K. (2010). An introduction to modern missing data analyses. Journal of School Psychology, 48(1), 5–37.CrossRefPubMed
39.
Zurück zum Zitat Lipkovich, I. A., Deberdt, W., Csernansky, J. G., Buckley, P., Peuskens, J., Kollack-Walker, S., et al. (2009). Defining “good” and “poor” outcomes in patients with schizophrenia or schizoaffective disorder: A multidimensional data-driven approach. Psychiatry Research, 170(2–3), 161–167.CrossRefPubMed Lipkovich, I. A., Deberdt, W., Csernansky, J. G., Buckley, P., Peuskens, J., Kollack-Walker, S., et al. (2009). Defining “good” and “poor” outcomes in patients with schizophrenia or schizoaffective disorder: A multidimensional data-driven approach. Psychiatry Research, 170(2–3), 161–167.CrossRefPubMed
Metadaten
Titel
How to interpret multidimensional quality of life questionnaires for patients with schizophrenia?
verfasst von
Pierre Michel
Pascal Auquier
Karine Baumstarck
Anderson Loundou
Badih Ghattas
Christophe Lançon
Laurent Boyer
Publikationsdatum
01.10.2015
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 10/2015
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-015-0982-y

Weitere Artikel der Ausgabe 10/2015

Quality of Life Research 10/2015 Zur Ausgabe